National Institute for Health and Care Excellence

Published: Guidance, quality standards and advice

Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C TA75 28 January 2004 27 November 2013 ...
National Institute for Health and Care Excellence

Published: Guidance, quality standards and advice

Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy TA1126 28 January 2026 28 January 2026 Concizumab for treating ...